This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kanda, H Articles by Mimura, T Search for Related Content PubMed PubMed Citation Articles by Kanda, H Articles by Mimura, T Social Bookmarking                         What's this?

Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan, hkanda-tky{at}umin.ac.jp

K Kubo

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan

S Tateishi

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan

K Sato

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan

A Yonezumi

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan

K Yamamoto

Department of Allergy and Rheumatology, University of Tokyo, Tokyo, Japan

T Mimura

Division of Rheumatology and Applied Immunology, Department of Medicine, Saitama Medical School, Saitama, Japan

Recent immunosuppressive treatments for lupus nephritis have improved renal survival rate, however, there still exists lupus nephritis refractory to these treatments. Angiotensin receptor blockers (ARBs) are known not only to decrease blood pressure but also to have an independent renoprotecting effect by interrupting renin-angiotensin system. The aim of this study was to evaluate whether ARBs have an additive effect on refractory lupus nephritis. Enrolled in this trial were twelve patients with lupus nephritis who were diagnosed by renal biopsy and remained proteinuria despite corticosteroids and/or immunosuppressive treatments. ARB, losartan or candesartan, was administered for six months. Various clinical parameters were compared before and after ARB administration. Proteinuria decreased after ARB treatment in 83% of the patients and the median amount of proteinuria significantly decreased from 2530 mg/gCr to 459 mg/gCr (P = 0.03). In addition, serum albumin and cholesterol levels were significantly improved. Systolic blood pressure significantly decreased, but none had symptoms of hypotension. The antiproteinuric effect of ARB did not correlate with the reduction of blood pressure. Interestingly, higher total complement activity levels before ARB treatment were associated with a greater reduction of proteinuria. The addition of ARB would be a safe and effective treatment for lupus nephritis with persistent proteinuria despite corticosteroids and/or immunosuppressive treatments.

Key Words: angiotensin II blocker • ARB • lupus nephritis • proteinuria

Lupus, Vol. 14, No. 4, 288-292 (2005)
DOI: 10.1191/0961203305lu2076oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S Masood, D Jayne, and Y Karim Beyond immunosuppression - challenges in the clinical management of lupus nephritis Lupus, February 1, 2009; 18(2): 106 - 115. [Abstract] [PDF]

				T. B. Kinane, E. F. Grabowski, A. Sharma, K. Nimkin, M. E. King, and L. D. Cornell Case 7-2008 -- A 17-Year-Old Girl with Chest Pain and Hemoptysis N. Engl. J. Med., February 28, 2008; 358(9): 941 - 952. [Full Text] [PDF]

				N. Kasitanon, M. Petri, M. Haas, L.S. Magder, and D.M. Fine Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases Lupus, January 1, 2008; 17(1): 40 - 45. [Abstract] [PDF]

				B. Ranchin and S. Fargue Review: New treatment strategies for proliferative lupus nephritis: keep children in mind! Lupus, August 1, 2007; 16(8): 684 - 691. [Abstract] [PDF]

				V Teplitsky, Y Shoenfeld, and A Tanay The renin-angiotensin system in lupus: physiology, genes and practice, in animals and humans Lupus, June 1, 2006; 15(6): 319 - 325. [Abstract] [PDF]